CFG
NAUT icon

Citizens Financial Group’s Nautilus Biotechnolgy NAUT Stock Holding History

Citizens Financial Group’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$93.5K Hold
50,000
– – ﹤0.01% 1029
2026
Q1 		$194K Buy
+50,000
New +$123K ﹤0.01% 809

Other funds holding NAUT

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $750M AUM 25.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CFM
Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
CA
Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return

Citizens Financial Group's NAUT Position: Q2 2026 in Review

Citizens Financial Group held its Nautilus Biotechnolgy (NAUT) position steady in Q2 2026 at 50,000 shares worth $93.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1029.

Citizens Financial Group first reported a position in NAUT in Q1 2026 and has held it in 2 quarters since. The position peaked at $194K in Q1 2026. 93 funds tracked by Wall St. Rank hold NAUT as of Q2 2026.

  • Citizens Financial Group held 50,000 shares of Nautilus Biotechnolgy worth $93.5K as of Q2 2026.
  • Citizens Financial Group left its Nautilus Biotechnolgy share count unchanged in Q2 2026.
  • Nautilus Biotechnolgy made up ﹤0.01% of Citizens Financial Group's portfolio in Q2 2026, its #1029 holding.
  • Citizens Financial Group first reported a position in Nautilus Biotechnolgy in Q1 2026 and has held it in 2 quarters since.
  • Citizens Financial Group's Nautilus Biotechnolgy position peaked at $194K in Q1 2026.
  • 93 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2026.

Based on Citizens Financial Group's 13F filing for Q2 2026, filed 7 Aug 2026.